Chandan Healthcare Board of Directors

Get the latest insights into the leadership at Chandan Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Mr. Amar Singh Chairman & Managing Director
Mr. Asmita Singh Managing Director
Mr. Vinay Lamba Non Executive Director
Mr. Amit Gupta Ind. Non-Executive Director
Mr. Brahma Nand Bhartiya Ind. Non-Executive Director
Mr. Vinod Jain Ind. Non-Executive Director

Chandan Healthcare Share price

CHANDAN

228.85

1.85 (0.81%)
NSE
BSE
Last updated on 4 Sep, 2025 | 15:28 IST
BUYSELL
Today's High

230.50

Today's Low

224.10

52 Week Low

140.00

52 Week High

279.00

The current prices are delayed, login to your account for live prices

Chandan Healthcare FAQs

The board at Chandan Healthcare consists of experienced professionals, including Mr. Amar Singh , Mr. Asmita Singh , and others, overseeing the company’s strategic and corporate governance.

Directors at Chandan Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Mr. Amar Singh is the current chairman at Chandan Healthcare.

Executive directors at Chandan Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Chandan Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Chandan Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.